Journal of Physiology & Pathology in Korean Medicine (동의생리병리학회지)

The Physiological Society of Korean Medicine and The Society of Pathology in Korean Medicine (대한동의생리학회·한의병리학회)
권호 표지

Influence of Gungguitang-gamibang on the Regulation of Melanogenesis through JNK Signaling Pathway in B16 Melanoma Cells

  • Jeong, Jae-Seong (Department of Pathology, College of Oriental Medicine, Wonkwang University) ;
  • Ju, Sung-Min (Department of Pathology, College of Oriental Medicine, Wonkwang University) ;
  • Kim, Kun-Jung (Department of Pathology, College of Oriental Medicine, Wonkwang University) ;
  • Kim, Eun-Cheol (Department of Oral & Maxillofacial Pathology, School of Dentistry, Wonkwang University) ;
  • Park, Hyun (Department of Infection Biology, College of Medicine, Wonkwang University) ;
  • Jeon, Byung-Hun (Department of Pathology, College of Oriental Medicine, Wonkwang University)
  • Published : 2005.02.25
Download PDF
⟨ Previous Next ⟩

Abstract

Gunggui-tang has been used for the therapy of blood disorders in Hangbang medicine for long time. Also, Glycyrrhiza uralensis has been used for deficientblood patterns with an irregular pulse or palpitations, coughing and wheezing, and heat or cold in the lungs. Melanogenesis is a physiological process resulting in the synthesis of melanin pigments. We investigated whether the water extract of Gunggui-tang plus G. uralensis inhibited melanogenesis in B16 melanoma cells. Because the molecular events connecting the regulation in tyrosinase activity remain to be elucidated, we also aimed to determine whether Gunggui-tang gamibang(GTG) affects tyrosinase at the gene activation level in the cells. First, we showed that GTG inhibited the tyrosinase promoter activity and further, down-regulated the tyrosinase protein activity in ${\alpha}-melanocyte-stimulating$ hormone $({\alpha}-MSH)-treated$ B16 melanoma cells. GTG also resulted in a decrease of melanin content in MSH-induced melanogenesis, indicating that GTG may be a useful drug in studying the regulation of melanogenesis. The pretreatment of GTG significantly prevented phosphotransferase activity of c-Jun N-terminal kinase (JNK1) and transcriptional activation of activating protein-1 (AP-1) in MSH-treated B16 melanoma cells. These findings indicate that GTG inhibits melanogenesis of B16 melanoma cells via suppression of phosphotransferase activity of JNK1 and transcriptional activation of AP-1.

Keywords

References

  1. Zhang GQ, Ji SG, Chai YF, Wu YT, Yin XP. Determination of glycyrrhizin in radix glycyrrhizae and its preparations by capillary zone electrophoresis. Biomed Chromatogr 13:407-409, 1999. https://doi.org/10.1002/(SICI)1099-0801(199910)13:6<407::AID-BMC901>3.0.CO;2-O
  2. Bensky D, Gamble A. Chinese herbal medicine: material medica, 8th edition. Eastland Press, pp. 463-466, 1986.
  3. Friedmann PS, Gilchrest BA. Ultraviolet radiation directly induces pigment production by cultured human melanocytes. J Cell Physiol 133:88-94, 1987. https://doi.org/10.1002/jcp.1041330111
  4. Hearing VJ. Biochemical control of melanogenesis and melanosomal organization. J Invest Dermatol Symp Proc 4:24-28, 1999. https://doi.org/10.1038/sj.jidsp.5640176
  5. Hunt G, Todd C, Cresswell JE, Thody AJ. Alphamelanocytestimulating hormone and its analogue NIe4DPhe7 alpha-MSH affect morphology, tyrosinase activity and melanogenesis in cultured human melanocytes. J Cell Sci 107:205-211, 1994.
  6. Hill SE, Buffey J, Thody AJ, Oliver I, Bleehen SS, Mac Neil S. Investigation of the regulation of pigmentation in alpha-melanocyte-stimulating hormone responsive and unresponsive cultured B16 melanoma cells. Pigment Cell Res 2:161-166, 1989. https://doi.org/10.1111/j.1600-0749.1989.tb00181.x
  7. Hoganson GE, Ledwitz-Rigby F, Davidson RL, Fuller BB. Regulation of tyrosinase mRNA levels in mouse melanoma cell clones by melanocyte-stimulating hormone and cyclic AMP. Somat Cell Mol Genet 15:255-263, 1989. https://doi.org/10.1007/BF01534876
  8. Hearing VJ, Jimenez M. Analysis of mammalian pigmentation at the molecular level. Pigment Cell Res 2:75-85, 1989. https://doi.org/10.1111/j.1600-0749.1989.tb00166.x
  9. Bertolotto C, Bille K, Ortonne J-P, Ballotti R. Regulation of tyrosinase gene expression by cAMP in B16 melanoma cells involves two CATGTG motifs surrounding the TATA box: implication of the microphthalmia gene product. J Cell Biol 134:747-755, 1996. https://doi.org/10.1083/jcb.134.3.747
  10. Englaro W, Derijard B, Ortonne JP, Ballotti R. Solar ultraviolet light activates extracellular signal-regulated kinases and the ternary complex factor in human normal keratinocytes. Oncogene 16:661-664, 1998. https://doi.org/10.1038/sj.onc.1201536
  11. Denhardt DT. Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: the potential for multiplex signalling. Biochem J 318:729-747, 1996.
  12. Ip YT, Davis RJ. Signal transduction by the c-Jun N-terminal kinase (JNK)--from inflammation to development. Curr Opin Cell Biol 10:205-219, 1998. https://doi.org/10.1016/S0955-0674(98)80143-9
  13. Abate C, Luk D, Gentz R. Rauscher FJ III, Curran T. Expression and purification of the leucine zipper and DNAbinding domains of Fos and Jun: both Fos and Jun contact DNA directly. Proc Natl Acad Sci USA 87:1032-1036, 1990. https://doi.org/10.1073/pnas.87.3.1032
  14. Pulverer BJ, Kyriakis JM, Avruch J, Nikolakaki E, Woodgett JR. Phosphorylation of c-jun mediated by MAP kinases. Nature 353:670-674, 1991. https://doi.org/10.1038/353670a0
  15. Kyriakis JM, Banerjee P, Nikolakaki E, Dai T, Rubie EA, Ahmad MF, Avruch J, Woodgett JR. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369:156-160, 1994. https://doi.org/10.1038/369156a0
  16. Hacker SM. Common disorders of pigmentation: when are more than cosmetic cover-ups required? Postgrad Med J 99:177-186, 1996.
  17. Martinez-Esparza M, Jimenez-Cervantes C, Solano F, Lozano JA, Garcia-Borron JC, Mechanisms and melanogenesis inhibition by tumor necrosis factor- in B16/F10 mouse melanoma cells. Eur J Biochem 225:139-146, 1998.
  18. Hosoi J, Abe E, Suda T, Kuroki T. Regulation of melanin synthesis of B16 mouse melanoma cells by 1 a-25-dihydroxyvitamin D3 and retinoic acid. Cancer Res 45:1474-1478, 1985.
  19. Jeong JY, Jue DM. Chloroquine inhibits processing of tumor necrosis factor in lipopolysaccharide-stimulated RAW 264.7 macrophages. J Immunol 158:4901-4907, 1997.
  20. Hearing VJ, Jimenez M. Mammalian tyrosinase-the critical regulatory control point in melanocyte pigmentation. Int J Biochem 19:1141-1147, 1987. https://doi.org/10.1016/0020-711X(87)90095-4
  21. Hearing VJ, Tsukamoto K. Enzymatic control of pigmentation in mammals. FASEB J 5:2902-2909, 1991,
  22. Aroca P, Urabe K, Kobayashi T, Tsukamoto K, Hearing VJ. Melanin biosynthesis patterns following hormonal stimulation. J Biol Chem 268:25650-25655, 1993.
  23. Quevedo WC Jr, Fitzpatrick TB, Szabo G, Jimbow K. Biology of melanocytes. In: Fitzpatrick TB, Eisen AZ, WolffK, Freedberg IM, Austen KF. editors. Dermatology in General Medicine, 3rd edition. New York: McGraw-Hill, pp. 224-251, 1987.
  24. Smeal T, Binetruy B, Mercola DA, Birrer M, Karin M. Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73. Nature 354:494-496, 1991. https://doi.org/10.1038/354494a0
  25. Korner A, Pawelek J. Activation of melanoma tyrosinase by a cyclic AMP-dependent protein kinase in a cell-free system. Nature 267:444-447, 1997. https://doi.org/10.1038/267444a0
  26. Oka M, Ogita K, Saito N, Mishima Y. Selective increase of the alpha subspecies of protein kinase C and inhibition of melanogenesis induced by retinoic acid in melanoma cells. J Invest Dermatol 100:204s-208s, 1993. https://doi.org/10.1111/1523-1747.ep12465200
  27. Park HY, Russakovsky V, Ohno S, Gilchrest BA. The beta isoform of protein kinase C stimulates human melanogenesis by activating tyrosinase in pigment cells. J Biol Chem 268:11742-11749, 1993.
  28. Englaro W, Rezzonico R, Durand-Clement M, Lallemand D, Ortonne JP, Ballotti R. Mitogen-activated protein kinase pathway and AP-1 are activated during cAMP-induced melanogenesis in B-16 melanoma cells. J Biol Chem 270:24315-24320, 1995. https://doi.org/10.1074/jbc.270.41.24315
  29. Jimbow K, Jimbow M. Chemical, pharmacologic and physical agents causing hypomelanoses. In: Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne J-J. eds, The pigmentary system Oxford: Oxford University Press, pp. 621-627, 1998.
  30. Levine N, Sheftel SN, Eytan T, Dorr RT, Hadley ME, Weinrach JC, Ertl GA, Toth K, McGee DL, Hruby VJ. Induction of skin tanning by subcutaneous administration of a potent synthetic melanotropin. JAMA 266:2730-2736, 1991. https://doi.org/10.1001/jama.266.19.2730
  31. Angel P, Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1072:129-157, 1991.
  32. Hibi M, Lin A, Smeal T, Minden A, Karin M. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev 7:2135-2148, 1993. https://doi.org/10.1101/gad.7.11.2135
  33. Pombo CM, Bonventre JV, Avruch J, Woodgett JR, Kyriakis JM, Force T. The stress-activated protein kinases are major c-Jun amino-terminal kinases activated by ischemia and reperfusion. J Biol Chem 269:26546-26551, 1994.
  34. Adler V, Schaffer A, Kim J, Dolan L, Ronai Z. UV irradiation and heat shock mediate JNK activation via alternate pathways. J Biol Chem 270:26071-26077, 1995. https://doi.org/10.1074/jbc.270.44.26071
  35. Mendelson KG, Contois LR, Tevosian SG, Davis RJ, Paulson KE. Independent regulation of JNK/p38 mitogen-activated protein kinases by metabolic oxidative stress in the liver. Proc Natl Acad Sci USA 93:12908-12913, 1996. https://doi.org/10.1073/pnas.93.23.12908